Circulating branched-chain amino acid concentrations are associated with obesity and future insulin resistance in children and adolescents
- PMID: 22961720
- PMCID: PMC3519972
- DOI: 10.1111/j.2047-6310.2012.00087.x
Circulating branched-chain amino acid concentrations are associated with obesity and future insulin resistance in children and adolescents
Abstract
What is already known about this subject Circulating concentrations of branched-chain amino acids (BCAAs) can affect carbohydrate metabolism in skeletal muscle, and therefore may alter insulin sensitivity. BCAAs are elevated in adults with diet-induced obesity, and are associated with their future risk of type 2 diabetes even after accounting for baseline clinical risk factors. What this study adds Increased concentrations of BCAAs are already present in young obese children and their metabolomic profiles are consistent with increased BCAA catabolism. Elevations in BCAAs in children are positively associated with insulin resistance measured 18 months later, independent of their initial body mass index.
Background: Branched-chain amino acid (BCAA) concentrations are elevated in response to overnutrition, and can affect both insulin sensitivity and secretion. Alterations in their metabolism may therefore play a role in the early pathogenesis of type 2 diabetes in overweight children.
Objective: To determine whether paediatric obesity is associated with elevations in fasting circulating concentrations of BCAAs (isoleucine, leucine and valine), and whether these elevations predict future insulin resistance.
Methods: Sixty-nine healthy subjects, ages 8-18 years, were enrolled as a cross-sectional cohort. A subset of subjects who were pre- or early-pubertal, ages 8-13 years, were enrolled in a prospective longitudinal cohort for 18 months (n = 17 with complete data).
Results: Elevations in the concentrations of BCAAs were significantly associated with body mass index (BMI) Z-score (Spearman's Rho 0.27, P = 0.03) in the cross-sectional cohort. In the subset of subjects that followed longitudinally, baseline BCAA concentrations were positively associated with homeostasis model assessment for insulin resistance measured 18 months later after controlling for baseline clinical factors including BMI Z-score, sex and pubertal stage (P = 0.046).
Conclusions: Elevations in the concentrations of circulating BCAAs are significantly associated with obesity in children and adolescents, and may independently predict future insulin resistance.
© 2012 The Authors. Pediatric Obesity © 2012 International Association for the Study of Obesity.
Figures
References
-
- Danaei G, Finucane MM, Lu Y, et al. National, regional, and global trends in fasting plasma glucose and diabetes prevalence since 1980: systematic analysis of health examination surveys and epidemiological studies with 370 country-years and 2.7 million participants. Lancet. 2011;378(9785):31–40. - PubMed
-
- Ten S, Maclaren N. Insulin resistance syndrome in children. J Clin Endocrinol Metab. 2004;89(6):2526–39. - PubMed
-
- Amiel SA, Sherwin RS, Simonson DC, Lauritano AA, Tamborlane WV. Impaired insulin action in puberty. A contributing factor to poor glycemic control in adolescents with diabetes. N Engl J Med. 1986;315(4):215–9. - PubMed
-
- Pinhas-Hamiel O, Zeitler P. The global spread of type 2 diabetes mellitus in children and adolescents. J Pediatr. 2005;146(5):693–700. - PubMed
-
- Felig P, Marliss E, Cahill GF., Jr Plasma amino acid levels and insulin secretion in obesity. N Engl J Med. 1969;281(15):811–6. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
- P30 DK040561/DK/NIDDK NIH HHS/United States
- K12 DK094723/DK/NIDDK NIH HHS/United States
- 5P30DK040561-15/DK/NIDDK NIH HHS/United States
- R01 DK081457/DK/NIDDK NIH HHS/United States
- M01 RR001066/RR/NCRR NIH HHS/United States
- K23 DK080658/DK/NIDDK NIH HHS/United States
- K24 DK064545/DK/NIDDK NIH HHS/United States
- UL1 RR025758/RR/NCRR NIH HHS/United States
- M01-RR-01066/RR/NCRR NIH HHS/United States
- R01 DK081572/DK/NIDDK NIH HHS/United States
- R01 HL130143/HL/NHLBI NIH HHS/United States
- 5R01 DK081572-03/DK/NIDDK NIH HHS/United States
- 1 UL1 RR025758-03/RR/NCRR NIH HHS/United States
- R03 DK084118/DK/NIDDK NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
